LogiPharma USA 2026 is shaping up to be one of the most substantive gatherings in pharmaceutical supply chain and logistics this year.
The event is drawing senior industry figures eager to address the mounting pressures facing drug supply networks across the United States and beyond.
Resilience is the headline theme, reflecting widespread industry concern about disruption risks that have tested pharmaceutical logistics operations in recent years.
Practical applications of artificial intelligence are also high on the agenda, with sessions designed to move beyond theoretical discussion and into real operational deployment.
LogiPharma’s Charleen Ring is among those previewing the 2026 agenda, offering attendees a guide to which sessions merit the closest attention across the programme.
McKesson’s Chris Van Norman is also featured in the event preview, lending the perspective of one of the largest pharmaceutical distribution companies in North America.
Van Norman is set to appear in a day two fireside chat, which organisers are positioning as one of the anchor conversations of the entire conference.
The fireside format reflects a broader shift in how LogiPharma is structuring peer engagement, with new formats designed to encourage more direct and candid exchange between senior practitioners.
These peer formats represent a deliberate departure from traditional panel discussions, giving participants more opportunity to share lived operational experience rather than prepared remarks.
The agenda signals that attendees are being asked to think about supply chain resilience not as a reactive capability but as something to be engineered deliberately and at scale.
AI features prominently not as a future consideration but as a present-tense challenge, with sessions focused on how organisations are actually integrating intelligent tools into supply chain decision-making today.
McKesson’s involvement underlines the significance of distribution infrastructure to the broader resilience conversation, given the company’s central role in moving medicines across the country.
The combination of strategic keynotes, peer-led formats, and senior executive fireside conversations gives the 2026 programme a notably practical orientation compared to previous years.
For supply chain professionals working in pharmaceutical and life sciences businesses, LogiPharma USA 2026 represents a key opportunity to benchmark approaches and stress-test existing strategies against industry peers.